MAIA BIOTECHNOLOGY INC (MAIA) Fundamental Analysis & Valuation

NYSEARCA:MAIA • US5526411021

Current stock price

1.33 USD
+0.03 (+2.31%)
At close:
1.32 USD
-0.01 (-0.75%)
After Hours:

This MAIA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MAIA Profitability Analysis

1.1 Basic Checks

  • MAIA had negative earnings in the past year.
  • MAIA had a negative operating cash flow in the past year.
  • In the past 5 years MAIA always reported negative net income.
  • MAIA had a negative operating cash flow in each of the past 5 years.
MAIA Yearly Net Income VS EBIT VS OCF VS FCFMAIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • MAIA has a Return On Assets of -230.78%. This is amonst the worse of the industry: MAIA underperforms 90.87% of its industry peers.
  • MAIA's Return On Equity of -942.64% is on the low side compared to the rest of the industry. MAIA is outperformed by 81.55% of its industry peers.
Industry RankSector Rank
ROA -230.78%
ROE -942.64%
ROIC N/A
ROA(3y)-240.36%
ROA(5y)-193.28%
ROE(3y)-1907.79%
ROE(5y)-1210.04%
ROIC(3y)N/A
ROIC(5y)N/A
MAIA Yearly ROA, ROE, ROICMAIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 2K -2K -4K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MAIA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAIA Yearly Profit, Operating, Gross MarginsMAIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MAIA Health Analysis

2.1 Basic Checks

  • MAIA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MAIA has been increased compared to 5 years ago.
  • There is no outstanding debt for MAIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MAIA Yearly Shares OutstandingMAIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
MAIA Yearly Total Debt VS Total AssetsMAIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -17.13, we must say that MAIA is in the distress zone and has some risk of bankruptcy.
  • MAIA has a worse Altman-Z score (-17.13) than 82.14% of its industry peers.
  • MAIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -17.13
ROIC/WACCN/A
WACCN/A
MAIA Yearly LT Debt VS Equity VS FCFMAIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

2.3 Liquidity

  • MAIA has a Current Ratio of 1.66. This is a normal value and indicates that MAIA is financially healthy and should not expect problems in meeting its short term obligations.
  • MAIA has a worse Current ratio (1.66) than 81.36% of its industry peers.
  • A Quick Ratio of 1.66 indicates that MAIA should not have too much problems paying its short term obligations.
  • MAIA has a worse Quick ratio (1.66) than 79.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
MAIA Yearly Current Assets VS Current LiabilitesMAIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MAIA Growth Analysis

3.1 Past

  • MAIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.78%, which is quite impressive.
EPS 1Y (TTM)35.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, MAIA will show a very strong growth in Earnings Per Share. The EPS will grow by 200.07% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.54%
EPS Next 2Y276.97%
EPS Next 3Y200.07%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAIA Yearly Revenue VS EstimatesMAIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 100M 200M 300M 400M
MAIA Yearly EPS VS EstimatesMAIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. MAIA Valuation Analysis

4.1 Price/Earnings Ratio

  • MAIA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MAIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAIA Price Earnings VS Forward Price EarningsMAIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MAIA Per share dataMAIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MAIA's earnings are expected to grow with 200.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y276.97%
EPS Next 3Y200.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MAIA Dividend Analysis

5.1 Amount

  • MAIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MAIA Fundamentals: All Metrics, Ratios and Statistics

MAIA BIOTECHNOLOGY INC

NYSEARCA:MAIA (4/30/2026, 8:04:00 PM)

After market: 1.32 -0.01 (-0.75%)

1.33

+0.03 (+2.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)03-23
Earnings (Next)05-07
Inst Owners4.15%
Inst Owner Change0%
Ins Owners7.89%
Ins Owner Change7.77%
Market Cap80.69M
Revenue(TTM)N/A
Net Income(TTM)-22.40M
Analysts82.86
Price Target12.38 (830.83%)
Short Float %5.32%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.6%
Min EPS beat(2)-39.32%
Max EPS beat(2)32.13%
EPS beat(4)3
Avg EPS beat(4)8.03%
Min EPS beat(4)-39.32%
Max EPS beat(4)32.13%
EPS beat(8)6
Avg EPS beat(8)20.14%
EPS beat(12)9
Avg EPS beat(12)15.45%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.16%
PT rev (3m)18.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 33.96
P/tB 33.96
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -230.78%
ROE -942.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-240.36%
ROA(5y)-193.28%
ROE(3y)-1907.79%
ROE(5y)-1210.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z -17.13
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-0.54%
EPS Next 2Y276.97%
EPS Next 3Y200.07%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-36.27%
EBIT Next 3Y59.64%
EBIT Next 5YN/A
FCF growth 1Y-19.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.99%
OCF growth 3YN/A
OCF growth 5YN/A

MAIA BIOTECHNOLOGY INC / MAIA Fundamental Analysis FAQ

What is the fundamental rating for MAIA stock?

ChartMill assigns a fundamental rating of 2 / 10 to MAIA.


What is the valuation status for MAIA stock?

ChartMill assigns a valuation rating of 1 / 10 to MAIA BIOTECHNOLOGY INC (MAIA). This can be considered as Overvalued.


How profitable is MAIA BIOTECHNOLOGY INC (MAIA) stock?

MAIA BIOTECHNOLOGY INC (MAIA) has a profitability rating of 0 / 10.